All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules

33Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The vitamin A derivative all-trans retinoic acid (ATRA) is considered as a potent chemotherapeutic drug for its capability of regulating cell growth and differentiation. We aimed to study the effect of ATRA on MMPp-9 in MDA-MB-231, human breast cancer cells and the probable molecular mechanisms through which ATRA exerts its effect.Results: Our experimental findings demonstrate that ATRA enters into the nucleus and regulates various signaling pathways viz. Integrin, FAK, EeRK, PpI-3K, NFκB and also EeGFR and downregulates pro-MMPp-9 activity as well as its expression. As a result MDA-MB-231 cell migration on fibronectin medium gets retarded in presence of ATRA. ATRA upregulates TIMPp-1 expression.Conclusions: Our study may help to understand the role of ATRA as a regulator of MMPp-9 and the possible signaling pathways which are involved in this ATRA mediated downregulation of MMP-9. © 2010 Landes Bioscience.

Author supplied keywords

Cite

CITATION STYLE

APA

Dutta, A., Sen, T., & Chatterjee, A. (2010). All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules. Cell Adhesion and Migration, 4(3), 409–418. https://doi.org/10.4161/cam.4.3.11682

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free